Illumina Newswire

Illumina Newswire

Comprehensive Real-Time News Feed for Illumina.

Results 1 - 20 of 641 in Illumina

  1. Insider Selling: Illumina, Inc. (ILMN) Director Sells 15,000 Shares of StockRead the original story w/Photo

    3 hrs ago | AmericanBankingNews.com

    Illumina, Inc. Director Jay T. Flatley sold 15,000 shares of the business's stock in a transaction on Tuesday, July 18th. The stock was sold at an average price of $170.77, for a total value of $2,561,550.00.

    Comment?

  2. Illumina, Inc. (NASDAQ:ILMN) Earns Underweight Rating from Morgan StanleyRead the original story w/Photo

    4 hrs ago | IntersportsWire

    ... of $115.00. Other equities analysts have also issued reports about the stock. TheStreet upgraded shares of Illumina from a c+ rating to a b rating in a research report on Thursday, April 6th. Vetr lowered shares of Illumina from a strong-buy rating ...

    Comment?

  3. Illumina, Inc. (ILMN) SVP Sells $25,264.80 in StockRead the original story w/Photo

    4 hrs ago | IntersportsWire

    Illumina, Inc. SVP Charles Dadswell sold 145 shares of the firm's stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $174.24, for a total value of $25,264.80.

    Comment?

  4. Illumina, Inc. (ILMN) EVP Sells $347,120.00 in StockRead the original story w/Photo

    13 hrs ago | Daily Political

    Illumina, Inc. EVP Marc Stapley sold 2,000 shares of Illumina stock in a transaction that occurred on Friday, July 14th. The stock was sold at an average price of $173.56, for a total transaction of $347,120.00.

    Comment?

  5. Dimensional Fund Advisors LP Increases Position in Illumina, Inc.Read the original story w/Photo

    17 hrs ago | IntersportsWire

    Dimensional Fund Advisors LP raised its position in shares of Illumina, Inc. by 3.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 264,925 shares of the life sciences company's stock after buying an additional 9,017 shares during the period.

    Comment?

  6. BidaskClub Upgrades Illumina, Inc. (NASDAQ:ILMN) to "Hold"Read the original story w/Photo

    Yesterday | IntersportsWire

    Several other equities analysts have also recently commented on ILMN. Evercore ISI upgraded Illumina from a hold rating to a buy rating and set a $190.00 target price for the company in a research report on Monday, February 27th.

    Comment?

  7. Regent Investment Management LLC Lowers Stake in Illumina, Inc.Read the original story w/Photo

    Wednesday | IntersportsWire

    Regent Investment Management LLC reduced its stake in Illumina, Inc. by 0.4% during the second quarter, according to its most recent filing with the SEC. The firm owned 4,060 shares of the life sciences company's stock after selling 15 shares during the period.

    Comment?

  8. Illumina, Inc. (ILMN) Stake Cut by Metropolitan Life Insurance Co. NYRead the original story w/Photo

    Wednesday | IntersportsWire

    Metropolitan Life Insurance Co. NY reduced its position in shares of Illumina, Inc. by 1.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

    Comment?

  9. Illumina's (NASDAQ:ILMN) "Hold" Rating Reiterated at Barclays PLCRead the original story w/Photo

    Tuesday | Daily Political

    ... reissued an "overweight" rating and issued a $187.00 price objective (up previously from $170.00) on shares of Illumina in a report on Friday, April 14th. Zacks Investment Research raised shares of Illumina from a "hold" rating to a "buy" rating and ...

    Comment?

  10. Advocacy Wealth Management Services LLC Continues to Hold Stake in Illumina, Inc.Read the original story w/Photo

    Tuesday Jul 18 | IntersportsWire

    Advocacy Wealth Management Services LLC maintained its position in Illumina, Inc. during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 600 shares of the life sciences company's stock at the end of the second quarter.

    Comment?

  11. Bank of Nova Scotia Boosts Stake in Illumina, Inc.Read the original story w/Photo

    Tuesday Jul 18 | IntersportsWire

    Bank of Nova Scotia raised its stake in shares of Illumina, Inc. by 265.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 86,202 shares of the life sciences company's stock after buying an additional 62,612 shares during the period.

    Comment?

  12. Neuberger Berman Group LLC Has $615,000 Position in Illumina, Inc.Read the original story w/Photo

    Monday Jul 17 | IntersportsWire

    Neuberger Berman Group LLC lowered its position in shares of Illumina, Inc. by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 3,607 shares of the life sciences company's stock after selling 122 shares during the period.

    Comment?

  13. Illumina, Inc. (NASDAQ:ILMN) Raised to "Strong-Buy" at Vetr Inc.Read the original story w/Photo

    Monday Jul 17 | IntersportsWire

    ... life sciences company's stock. Several other analysts also recently issued reports on ILMN. Leerink Swann raised Illumina from a market perform rating to an outperform rating and set a $195.00 price target on the stock in a research note on Monday, ...

    Comment?

  14. Windward Capital Management Co. CA Has $4.12 Million Position in Illumina, Inc.Read the original story w/Photo

    Monday Jul 17 | IntersportsWire

    Windward Capital Management Co. CA boosted its stake in shares of Illumina, Inc. by 1.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission.

    Comment?

  15. Gateway Investment Advisers LLC Has $17.28 Million Position in Illumina, Inc.Read the original story w/Photo

    Thursday Jul 13 | IntersportsWire

    Gateway Investment Advisers LLC cut its stake in shares of Illumina, Inc. by 6.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The fund owned 99,606 shares of the life sciences company's stock after selling 6,926 shares during the period.

    Comment?

  16. Creative Planning Has $3.57 Million Position in Illumina, Inc.Read the original story w/Photo

    Thursday Jul 13 | Daily Political

    Creative Planning lowered its stake in Illumina, Inc. by 26.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,560 shares of the life sciences company's stock after selling 7,391 shares during the period.

    Comment?

  17. Illumina, Inc. (NASDAQ:ILMN) Upgraded to Strong-Buy at Vetr Inc.Read the original story w/Photo

    Friday Jul 7 | IntersportsWire

    ... reaffirmed an overweight rating and issued a $187.00 price objective (up previously from $170.00) on shares of Illumina in a research note on Friday, April 14th. Zacks Investment Research raised shares of Illumina from a hold rating to a buy rating ...

    Comment?

  18. Illumina, Inc. to Post FY2018 Earnings of $4.35 Per Share, Cantor Fitzgerald ForecastsRead the original story w/Photo

    Friday Jul 7 | IntersportsWire

    Cantor Fitzgerald issued their FY2018 earnings estimates for shares of Illumina in a research report issued on Friday. Cantor Fitzgerald analyst B. Brokmeier expects that the life sciences company will earn $4.35 per share for the year.

    Comment?

  19. Illumina, Inc. (ILMN) Upgraded to Strong-Buy at Vetr Inc.Read the original story w/Photo

    Thursday Jul 6 | Daily Political

    ... company's stock. Several other research analysts have also recently weighed in on the company. BidaskClub upgraded Illumina from a sell rating to a hold rating in a research report on Saturday, June 24th. Morgan Stanley reiterated an underweight ...

    Comment?

  20. Illumina, Inc. (NASDAQ:ILMN) Position Lowered by United Services Automobile AssociationRead the original story w/Photo

    Thursday Jul 6 | The Breeze

    United Services Automobile Association lowered its position in Illumina, Inc. by 0.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 89,393 shares of the life sciences company's stock after selling 701 shares during the period.

    Comment?